收藏切换
The efficacy of dapagliflozin combined with valsartan in the treatment of diabetic nephropathy and its influence on cystatin C and renal function
收藏切换
Jijie JIANG1a, Shibin HAN1b, Mengxu LI2, *
World Clinical Drug | 2025, 46(9) : 915 - 920
Less
收藏切换
World Clinical Drug | 2025, 46(9): 915-920
• Article •
The efficacy of dapagliflozin combined with valsartan in the treatment of diabetic nephropathy and its influence on cystatin C and renal function
Full
Jijie JIANG1a, Shibin HAN1b, Mengxu LI2, *
Affiliations
  • 1a.Department of Critical Care Medicine, Linquan County People's Hospital, Fuyang 236400, Anhui Province, China
  • 1b.Department of Endocrinology, Linquan County People's Hospital, Fuyang 236400, Anhui Province, China
  • 2.Department of Endocrinology, Fuyang Second People's Hospital, Fuyang 236015, Anhui Province, China
Published: 2025-09-10 doi: 10.13683/j.wph.2025.09.007
Outline
收藏切换
Objective

To explore the effect of dapagliflozin combined with valsartan in the treatment of diabetic nephropathy(DN) and its influence on cystatin(Cys)-C.

Methods

A total of 110 patients with DN who visited the endocrinology department of Linquan county people's hospital from June 2022 to January 2025 were selected as the research subjects and randomly divided into the observation group and the control group, with 55 cases in each group. The control group was treated with dapagliflozin, while the observation group was treated with dapagliflozin combined with valsartan. The treatment courses were 8 weeks for both groups. After treatment, the clinical efficacy, Cys-C, urinary albumin excretion rate(UAER), β2-globulin(β2-MG), serum creatinine(Scr), fasting palsma glucose(FPG), 2-hour postprandial blood glucose(2hPG), glycosylated hemoglobin(Hb)A1c, erythrocyte sedimentation rate(ESR), C-reactive protein(CRP), serum amyloid protein(SA)A levels and the occurrence of adverse reactions during the treatment period of the two groups were compared.

Results

After treatment, the total effective rate of the observation group was higher than that of the control group(87.27% vs. 70.91%, P<0.05). The levels of Cys-C, UAER, β2-MG, Scr, ESR, CRP, SAA, FPG, 2hPG and HbA1c in both groups were lower than those before treatment(P<0.05), and those in the observation group were lower than those in the control group(P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups(P>0.05).

Conclusion

Dapagliflozin combined with valsartan has a better therapeutic effect on DN. It can improve Cys-C and renal function, and contribute to the reduction of inflammatory factors levels.

diabetic nephropathy  /  dapagliflozin  /  valsartan  /  cystatin C  /  renal function  /  inflammatory factor
蒋继杰, 韩士彬, 李梦旭. 达格列净联合缬沙坦对糖尿病肾病效果及对胱抑素C和肾功能影响. 世界临床药物, 2025 , 46 (9) : 915 -920 . DOI: 10.13683/j.wph.2025.09.007
Jijie JIANG, Shibin HAN, Mengxu LI. The efficacy of dapagliflozin combined with valsartan in the treatment of diabetic nephropathy and its influence on cystatin C and renal function[J]. World Clinical Drug, 2025 , 46 (9) : 915 -920 . DOI: 10.13683/j.wph.2025.09.007
Year 2025 volume 46 Issue 9
50
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.09.007
  • Receive Date:2025-05-08
  • Online Date:2026-11-09
  • Published:2025-09-10
Article Data
Affiliations
History
  • Received:2025-05-08
Affiliations
    1a.Department of Critical Care Medicine, Linquan County People's Hospital, Fuyang 236400, Anhui Province, China
    1b.Department of Endocrinology, Linquan County People's Hospital, Fuyang 236400, Anhui Province, China
    2.Department of Endocrinology, Fuyang Second People's Hospital, Fuyang 236015, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT